DeCure for Intellectual developmental disorder with autistic features and language delay, with or without seizures
DeCure's autonomous Neuro AI scientist is researching a drug-repurposing hypothesis for intellectual developmental disorder with autistic features and language delay, with or without seizures — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleIntellectual developmental disorder with autistic features and language delay, with or without seizures maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for intellectual developmental disorder with autistic features and language delay, with or without seizures is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
What the evidence adds up to
A 1997 case report described autistic twins with absence seizures, each having 50–60 staring spells per day. After starting valproic acid, their seizures were controlled and the authors reported a “dramatically accelerated rate of acquisition of both language and social skills.” The report involved two boys and had no control group. No other study in this set tested any drug.
A 2003 follow-up study of 18 children (mean age 4 years 4 months at entry) who had a communication disorder and some autistic-like behaviours but did not meet ICD-10 criteria for childhood autism found that by mean age 8 years 7 months, all 18 met diagnostic criteria for either autism or autistic spectrum disorder. Nine children still had a significant communication disorder; of those, five now met criteria for autism and four for autistic spectrum disorder. The other nine had resolved their communication disorder but still met criteria for autistic spectrum disorder. None of the children had resolution of their autistic-like behaviours. The authors concluded there was no subgroup in which improving communication led to disappearance of autistic features.
A 1987 comparison of children from a psychiatric clinic found that those with language delay were highly likely to have a diagnosis of mental retardation or infantile autism. Very few psychiatric symptoms occurred more frequently in the language-delay group than in the age- and sex-matched control group, and those that did were characteristic of retarded or autistic children. The language-delay group was more likely to have other developmental abnormalities, hearing impairment, and evidence of central nervous system dysfunction.
What is still missing is any controlled trial of valproic acid or any other drug for the core features of intellectual developmental disorder with autistic features and language delay, with or without seizures. The 1997 report is limited to two boys and cannot separate drug effect from natural history or placebo effect. No study in this set addresses patient stratification by genetic subtype, seizure type, or language profile. No funding for a randomised trial in this specific population has been reported.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Journal of Neuroscience Nursing · 1997 · 49 citations
Valproic Acid Treatment of Epilepsy in Autistic Twins
AbstractCase histories of autistic twins with absence seizures are presented. The boys had autistic features prior to the onset of seizures during their second year of life. By age 3 years, the twins were significantly delayed in the areas of socialization, communications and impulse control. Typical autistic features were pronounced, including perseverative, nonpurposeful and self-stimulatory behaviors; lack of symbolic play; poor eye contact; echolalic and noncommunicative speech; and unresponsiveness to disciplinary efforts. The absence seizures, although first observed by the parents early in the twins' second year, were not diagnosed until age 3 years 1 month. The seizures consisted of 50-60 staring spells per day. Both boys responded to valproic acid treatment with control of their seizures and with a dramatically accelerated rate of acquisition of both language and social skills. A possible causal relationship between autism and absence seizures in these children is explored.
Psychiatric Symptomatology in Language-Impaired Childrén: A Comparison
AbstractThis paper reports a detailed comparison of two groups of children from the same psychiatric clinic, one with a delay in language development and an age- and sex-matched control group with no such delay. The language-delay group was highly likely to have either a diagnosis of mental retardation or infantile autism. Very few psychiatric symptoms occurred more frequently in the language-delay group than in the comparison group, and those that did were characteristic of retarded or autistic children. The language-delay group was more likely to have other developmental abnormalities, hearing impairment, and evidence of central nervous system dysfunction.
AbstractSource: Michelotti J, Charman T, Slonims V, et al. Follow-up of children with language delay and features of autism from preschool years to middle childhood. Devel Med Child Neurol. 2002;44:812–819.Investigators from City and Hackney Community Services, NHS Trust in London, UK, hypothesized that children with communication disorders and autistic like behaviors would, over time, fall into 1 of 2 subgroups: 1) those who, when their communication disorder improved, would also exhibit a disappearance of their autistic-like features (because these impaired socialization skills were simply secondary to the communication deficit); and 2) those who, whether or not they had a continuing communication disorder diagnosis, would exhibit an increase in autistic-like behaviors such that they would later qualify for a diagnosis of autism or an autistic spectrum disorder.Eighteen children (15 boys, 16 Caucasians) diagnosed with a communication disorder with some autistic-like behaviors at a mean age of 4 years and 4 months but who did not meet the ICD-10 diagnostic criteria for childhood autism were studied. Reassessment at a mean age of 8 years and 7 months found that 9 of the children still had a significant communication disorder and that of these 9, 5 now met diagnostic criteria for autism while the remaining 4 met diagnostic criteria for autistic spectrum disorder. The other 9 children had resolved their communication disorder but now also met diagnostic criteria for autistic spectrum disorder.The authors found that none of the children had resolution of their autistic-like behaviors, suggesting that there is not a subgroup of children who, when their communication disorder improved, would also exhibit a disappearance of their autistic-like features.Today there is a marked increase in the incidence of autism, and many practitioners are rightfully wary of over-diagnosis. The most common developmental disorder in young children is language delay, and the more severe the language delay, the more likely is the associated presence of several autistic-like behaviors. These behaviors are rarely of sufficient severity to warrant a diagnosis of autism or an autistic spectrum disorder. The authors report that in children identified early with significant communication disorders and accompanying autistic features, the long-term outcome was that all the children finally met diagnostic criteria for autism or an autistic spectrum disorder.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
